Wendy W Wu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Amyotrophic Lateral Sclerosis

Catheter Ablation

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Wendy W Wu, Moran Choe, Lars Johannesen, José Vicente, Girish Bende, Norman L Stockbridge, David G Strauss, Christine Garnett
ICH S7B in vitro assays do not address mechanisms of QT C prolongation for peptides and proteins - data in support of not needing dedicated QT C studies. Clinical pharmacology and therapeutics (2023)
Ming Ren, Aaron L Randolph, Claudia Alvarez-Baron, Donglin Guo, Phu N Tran, Nicolas Thiebaud, Jiansong Sheng, Jun Zhao, Wendy W Wu
Experimental factors that impact CaV1.2 channel pharmacology-Effects of recording temperature, charge carrier, and quantification of drug effects on the step and ramp currents elicited by the "step-step-ramp" voltage protocol. PloS one 17 (11) (2022)
Phu N Tran, Jiansong Sheng, Aaron L Randolph, Claudia Alvarez Baron, Nicolas Thiebaud, Ming Ren, Min Wu, Lars Johannesen, Donna A Volpe, Dakshesh Patel, Ksenia Blinova, David G Strauss, Wendy W Wu
Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block. PloS one 15 (11) (2020)